<?xml version='1.0' encoding='utf-8'?>
<document id="27450228"><sentence text="Physiologically Based Absorption Modeling to Explore the Impact of Food and Gastric pH Changes on the Pharmacokinetics of Alectinib."><entity charOffset="122-131" id="DDI-PubMed.27450228.s1.e0" text="Alectinib" /></sentence><sentence text="Alectinib, a lipophilic, basic, anaplastic lymphoma kinase (ALK) inhibitor with very low aqueous solubility, has received Food and Drug Administration-accelerated approval for the treatment of patients with ALK+ non-small-cell lung cancer"><entity charOffset="0-9" id="DDI-PubMed.27450228.s2.e0" text="Alectinib" /></sentence><sentence text=" This paper describes the application of physiologically based absorption modeling during clinical development to predict and understand the impact of food and gastric pH changes on alectinib absorption"><entity charOffset="182-191" id="DDI-PubMed.27450228.s3.e0" text="alectinib" /></sentence><sentence text=" The GastroPlusâ„¢ software was used to develop an absorption model integrating in vitro and in silico data on drug substance properties" /><sentence text=" Oral pharmacokinetics was simulated by linking the absorption model to a disposition model fit to pharmacokinetic data obtained after an intravenous infusion" /><sentence text=" Simulations were compared to clinical data from a food effect study and a drug-drug interaction study with esomeprazole, a gastric acid-reducing agent"><entity charOffset="108-120" id="DDI-PubMed.27450228.s6.e0" text="esomeprazole" /></sentence><sentence text=" Prospective predictions of a positive food effect and negligible impact of gastric pH elevation were confirmed with clinical data, although the exact magnitude of the food effect could not be predicted with confidence" /><sentence text=" After optimization of the absorption model with clinical food effect data, a refined model was further applied to derive recommendations on the timing of dose administration with respect to a meal" /><sentence text=" The application of biopharmaceutical absorption modeling is an area with great potential to further streamline late stage drug development and with impact on regulatory questions" /><sentence text="" /></document>